Female Synthetic Hormone Nafarelin Acetate (synarel) 76932-56-4 for Treating Endometriosis
- Hersteller: Dewael
- Produkttest: 99%+
- Aussehen:White lyophilized powder
- Herkunftsort: China
- Zertifizierung: SGS,ISO9001, GMP
- Mindestbestellmenge: 100ml
- Verpackungsinformationen: Diskreter Möglichkeiten der Verpackung für den Zoll garantiert
- Lieferzeit: Innerhalb 12 Stunden nach Eingang Ihrer Zahlung
- Zahlungsbedingungen: Western Union, Moneygram,Bitcoin,Banküberweisung
- Versand: EMS,DHL,Fedex,UPS,TNT und so weiter.
- Politik: Re-Schifffahrtspolitik
- Lieferfähigkeit: 500-600Liter / Monat
Female Synthetic Hormone Nafarelin Acetate (synarel) 76932-56-4 for Treating Endometriosis
Nafarelin Acetate (synarel) Einzelheiten:
Produktname | Nafarelin Acetate |
CAS-NR. | 76932-56-4 |
Synonyme | Nafarelin Acetate |
Category | Pharmaceutical Raw Materials,Active Pharmaceutical Ingredients,Bulk Drugs,Fine Chemicals. |
Reinheit | 99% Nafarelin Acetate |
Aussehen | Nafarelin Acetate powder |
Haltbarkeit | 2 years for Nafarelin Acetate |
Verwendung | Nafarelin Acetate is used in female infertility and endometriosis. |
Lager | Nafarelin Acetate should be stored in a well-closed containerat low temperature, keep away from moisture, heat and light. |
Beschreibung
Its proposed mechanism of action could be the desensitization of pituitary GnRH receptors resulting in a decrease in gonadotropin release, and ovarian hormone serum concentrations much like those achieved in postmenopausal women. Nafarelin is administered by nasal inhalation and contains been generally well tolerated. It is associated with a high incidence of adverse effects but they are rarely severe enough to cause withdrawal from treatment, the ones occurring most frequently–hot flashes, vaginal dryness, and decreased libido–are a result of the hypoestrogenemia induced through the drug. Increased bone turnover is situated women on nafarelin but biochemical parameters resume pretreatment concentrations by six months after termination of treatment. This agent’s invest the therapy of endometriosis will be determined as clinical experience accumulates.
Nafarelin Acetate Application:
Treating endometriosis, including relieving pain and reducing lesions. It is usually used to treat early puberty (central precocious puberty [CPP]) in children of both sexes. It could be used for other difficulties as determined by your doctor.
Nafarelin is really a gonadotropin-releasing hormone (GnRH) agonist. It functions by decreasing creation of certain steroids in your body, which decreases the symptoms of endometriosis or early puberty.
Echtheitszertifikat
Item | Spezifikation | Result |
Aussehen | White powder | Entspricht |
Identifikation | Positiv | Entspricht |
Test | 98.0% min | 98.2% |
Verlust beim Trocknen | 6.0%max. | 5.8% |
Acetatgehalt(durch HPLC) | 10.0%max. | 9.8% |
Peptide Content (N%) | 80.0%min. | 88.0% |
Amino Acid Composition | ±10% of theoretical | Entspricht |
Single Impurity (HPLC) | 1.0%max. | 0.45% |
MS(ESI) | Consistent | Entspricht |
Mass Balance | 95.0~105.0% | 98.0% |
———————————————————————————————————————————————————————————————————————————————————————-
Kontaktieren Sie mich jetzt
Bewertungen
Es gibt noch keine Kommentare.